Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetically modified immune cells targeting tumor antigens

15 Jun 2020

Abstract excerpt

Immunotherapy approaches consisting of genetically modified immune cells have become a promising platform for cancer treatment. Such 'living' therapies targeting tumor antigens have shown success in many cancer patients in the form of durable responses in a growing number of clinical studies. Besides, a large number of ongoing studies have been designed to introduce reliable methods for identification of tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Research and Treatments
Share to CAR-T cell therapy research
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32553789
DOI: 10.1016/j.pharmthera.2020.107603

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetically modified immune cells targeting tumor antigensPMID 32553789Read ↗

Genetically modified T cells in cancer therapy: opportunities and challengesSemantic proximity Read ↗

Current and future concepts for the generation and application of genetically engineered CAR-T and TCR-T cellsSemantic proximity Read ↗

Genetically engineered T cells for cancer immunotherapySemantic proximity Read ↗

Genetically engineered T cells for the treatment of cancerSemantic proximity Read ↗

Clinical application of genetically modified T cells in cancer therapySemantic proximity Read ↗

Adoptive T‐cell therapy for cancer: The era of engineered T cellsSemantic proximity Read ↗

Genetically Redirected T Lymphocytes for Adoptive Immunotherapy of Solid TumorsSemantic proximity Read ↗

Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapySemantic proximity Read ↗

Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies.Semantic proximity Read ↗

Strategies to genetically engineer T cells for cancer immunotherapySemantic proximity Read ↗

The Flipside of the Power of Engineered T Cells: Observed and Potential Toxicities of Genetically Modified T Cells as TherapySemantic proximity Read ↗

Emerging Cellular Therapies for CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.